Zobrazeno 1 - 3
of 3
pro vyhledávání: '"HCV late relapse"'
Autor:
Claudia Minosse, Cesare E. M. Gruber, Martina Rueca, Chiara Taibi, Mauro Zaccarelli, Elisabetta Grilli, Marzia Montalbano, Maria R. Capobianchi, Andrea Antinori, Gianpiero D’Offizi, Fiona McPhee, Anna Rosa Garbuglia
Publikováno v:
Viruses, Vol 13, Iss 6, p 1151 (2021)
The risk of hepatitis C virus (HCV) recurrence after direct-acting antiviral (DAA) treatment is Z-score of
Externí odkaz:
https://doaj.org/article/a59e77ab3cf4494a843a5c658c89343a
Autor:
Cesare Ernesto Maria Gruber, Marzia Montalbano, Gianpiero D'Offizi, Martina Rueca, Andrea Antinori, Chiara Taibi, Maria Rosaria Capobianchi, Claudia Minosse, Mauro Zaccarelli, Anna Rosa Garbuglia, Fiona McPhee, Elisabetta Grilli
Publikováno v:
Viruses
Viruses, Vol 13, Iss 1151, p 1151 (2021)
Volume 13
Issue 6
Viruses, Vol 13, Iss 1151, p 1151 (2021)
Volume 13
Issue 6
The risk of hepatitis C virus (HCV) recurrence after direct-acting antiviral (DAA) treatment is <
0.5%. However, the distinction between HCV RNA late relapse and reinfection still represents a challenge in virological diagnostics. The aim of t
0.5%. However, the distinction between HCV RNA late relapse and reinfection still represents a challenge in virological diagnostics. The aim of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f0dcb420f1bf245db711cc14163f4dc
http://europepmc.org/articles/PMC8235384
http://europepmc.org/articles/PMC8235384
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.